Skip to main content
. Author manuscript; available in PMC: 2020 Apr 1.
Published in final edited form as: Cancer Epidemiol Biomarkers Prev. 2019 Jan 2;28(4):707–714. doi: 10.1158/1055-9965.EPI-18-1014

Figure 2.

Figure 2.

Downstream consequences of low PLZF in HPFS and PHS. A, PLZF mRNA expression and a signature of MAPK signaling (n = 404). Horizontal lines indicate the medians; boxes reach from the first to the third quartiles; whiskers extend 1.5 times the interquartile range. B, PLZF mRNA expression and risk of lethal disease over long-term follow-up in a multivariable model adjusting for patient, histologic, and genomic covariates.